Respiratory Medicine, Allergology, and Palliative Medicine
781 – 790 of 1394
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
IL-17A is Elevated in End-stage COPD and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.
(
- Contribution to journal › Article
-
Mark
Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
(
- Contribution to journal › Article
-
Mark
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
(
- Contribution to journal › Article
-
Mark
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation.
(
- Contribution to journal › Article
-
Mark
Versican in inflammation and tissue remodelling: the impact on lung disorders.
(
- Contribution to journal › Scientific review
-
Mark
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
(
- Contribution to journal › Article
-
Mark
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.
(
- Contribution to journal › Article
-
Mark
Obesity and asthma: current knowledge and future needs
(
- Contribution to journal › Scientific review
-
Mark
Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat(®) Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
(
- Contribution to journal › Article